Perspective Therapeutics, Inc.

CATXAMEX • USD
ThemeHealthcare - Oncology›Radiopharmaceuticals & ADCs
2.99 USD
↗ 0.04 (1.36%)AT CLOSE (11:59 AM EDT)
2.98
↘ 0.01 (0.33%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
2.98
↘ 0.01 (0.33%)
🟢Market: OPEN

Perspective Therapeutics, Inc. (CATX) trades at $3.12 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Strong Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 17, 2026.

Open?$2.93
High?$3.01
Low?$2.88
Prev. Close?$2.95
Volume?1.0M
Avg. Volume?2.3M
VWAP?$2.97
Rel. Volume?0.43x
Bid / Ask
Bid?$2.88 × 200
Ask?$2.99 × 200
Spread?$0.11
Midpoint?$2.94
Valuation & Ratios
Market Cap?336.4M
Shares Out?114.0M
Float?94.7M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?0.97
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Themes
Healthcare - Oncology›Radiopharmaceuticals & ADCs
Employees
166
Market Cap
336.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.perspectivetherapeutics.com
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
26
Momentum?
3
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?1.71Distress
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.00%Squeeze Risk
Short Interest?22.7M
Days to Cover?7.3
Free Float94.7M
Avg Daily Volume3.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?1.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.97CHEAP▾
P/S?
Peers
100
S&P
3
544.40HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
459.67HIGH▾
Returns & Efficiency
ROE?
S&P
6
-32.0%WEAK▾
ROA?
S&P
3
-27.1%WEAK▾
Cash Flow & Enterprise
FCF?$-107447000
Enterprise Value?$284.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist